Mineralys Therapeutics (MLYS) FCF Margin (2022 - 2026)
Mineralys Therapeutics (MLYS) reported FCF Margin of -656.32% for Q2 2026, up 212.11 percentage points from -868.42% a year earlier and up 2.46 percentage points from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) FCF Margin (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Mineralys Therapeutics' FCF Margin came in at -654.97%, up 912.38 percentage points year-over-year; for FY2025, it was -892.82%, up 247.92 percentage points from FY2024.
- FCF Margin has a three-year change of +850.68 percentage points (FY2022 to FY2025).
- By year, FCF Margin came in at -1140.73% in FY2024 (-504.38 pp), -636.35% in FY2023 (+1107.14 pp) and -1743.50% in FY2022.
- Five-year quarterly FCF Margin spans a low of -2379.60% in Q4 2024 and a high of -498.26% in Q1 2024.
- Year over year, FCF Margin has now increased in each of the last four quarters, with an average year-over-year change of +1.05 percentage points over the last eight quarters.
- The high point for year-over-year FCF Margin in five years was Q4 2025 (a gain of 1752.59 percentage points); the low point was Q1 2025 (a drop of 1533.32 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -658.77% (Q1 2026), -627.01% (Q4 2025) and -688.25% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 28.96% |
| 10 | Mineralys Therapeutics | 1.42 Bn | -1.17 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -656.32% |
| Mar 31, 2026 | -658.77% |
| Dec 31, 2025 | -627.01% |
| Sep 30, 2025 | -688.25% |
| Jun 30, 2025 | -868.42% |
| Mar 31, 2025 | -2,031.58% |
| Dec 31, 2024 | -2,379.60% |
| Sep 30, 2024 | -1,330.76% |
| Jun 30, 2024 | -726.06% |
| Mar 31, 2024 | -498.26% |
| Dec 31, 2023 | -872.66% |
| Sep 30, 2023 | -541.73% |
| Jun 30, 2023 | -567.38% |
| Mar 31, 2023 | -548.52% |
| Dec 31, 2022 | -1,089.41% |
| Sep 30, 2022 | -943.05% |
API Access
Mineralys Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();